Tag: Diabetes Supplies
CGM: Make the box work harder
June 10, 2026Brett Siegal
Q. I’m already paying for CGM resupply shipments to go out every 30 or 90 days. Is there a way to make those boxes work harder for my business?
A. Yes – every box your distributor ships is a marketing opportunity most providers are leaving on the table.
Package inserts are the highest open-rate marketing method available to DME providers. (Almost) every shipment gets opened, providing a near-guaranteed marketing impression with every delivery. Some providers are not using package...
Finnegan Health Services buys Eclipse Medical
May 5, 2026HME News Staff
CONWAY, Ark. – Finnegan Health Services has acquired Eclipse Medical, a North Little Rock, Ark.-based provider specializing in diabetes and urology supplies. The deal expands Finnegan’s product offerings, enhances its operational scale and deepens its relationships with physicians, payers and health care partners.
“Eclipse Medical is a natural fit with our mission to deliver high-quality, patient-centered care,” said Todd Ross, President & CEO of Finnegan Health Services....
Bodlund moves to president and CEO at Ascensia
February 26, 2026HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care has appointed Peter Bodlun as president and CEO, effective April 1. Bodlund, who most recently served as Ascensia’s COO, succeeds Koichiro Sato, who will continue as COO of parent company PHC Group and head of PHC Group’s Diabetes Management business. The leadership transition reflects Ascensia’s sustained performance and continued focus on long-term growth, executional excellence, and sustained value creation, the company says. “Ascensia...
AAHomecare launches resources to highlight role of DME suppliers in CGM access
September 10, 2025HME News Staff
ARLINGTON, Va. – AAHomecare has developed new turnkey resources to help diabetes-focused suppliers demonstrate the value of prescribing CGM therapy through the DME channel.
As CMS has expanded coverage of CGMs and supplies, some payers have begun making it a pharmacy-only benefit, limiting brand choices and narrowing networks. These resources are designed to support conversations with referral sources and certified diabetes educators, reinforcing the critical role of DME suppliers...
Diabetes resupply: Preserve dual access
August 12, 2025Matt Edwards
Q. Why does the path to a CGM matter, and should patient choice lead the way?
A. The way a patient receives their CGM—through a pharmacy or a DME provider—can have a meaningful impact on adherence, outcomes and health care costs. That’s why it’s essential to protect patient and physician choice in determining the best delivery channel.
Studies consistently show that the DME pathway supports stronger adherence and long-term success. One study in JMIR Diabetes...
Diabetes resupply: Train early, often
July 8, 2025Matt Edwards
Q. What challenges should I expect when managing CGM resupply—and how do I overcome them?
A. There are several operational, regulatory and clinical challenges to overcome, but understanding and proactively addressing potential challenges at the start of a CGM program is key to its success and sustainability.
Insurance complexity is a common challenge. CGM products may fall under both pharmacy and medical benefits, which can confuse patients and providers. Pharmacy and...
Diabetes Resupply: Establish infrastructure
June 17, 2025Matt Edwards
Q. How do HME businesses get started with a CGM resupply program?
A. Most HME providers already possess the foundational capabilities needed for a CGM resupply program—such as patient outreach, billing expertise and established provider relationships. Success lies in integrating these assets into a scalable, compliant and patient-centered model.
The first step is to review payer contracts. Continuous glucose monitors may be covered under the medical benefit (via...
AdaptHealth’s diabetes biz continues to lag
May 9, 2025Theresa Flaherty
CONSHOHOCKEN, Pa. – AdaptHealth is still playing catch-up with its diabetes business, keeping the company from delivering “enterprise level organic growth,” says CEO Suzanne Foster.
For the first quarter of 2025, the Diabetes Health segment’s net revenue declined 8% year over year to $138.8 million.
“We cannot deliver enterprise level organic growth that meets or exceeds market growth, if our Diabetes Health segment is underperforming,” said CEO...
Sleep, diabetes ‘lead the way’ at Owens & Minor
May 9, 2025Theresa Flaherty
RICHMOND, Va. – Owens & Minor delivered on almost all expectations for the first quarter of 2025, with the Patient Direct segment performing “exceedingly well,” say company executives.
Patient Direct revenue was $674 million for the first quarter of 2025, a 6% increase compared to the same period last year. On a same-day basis, revenue increased 7.3% year over year, said CEO Edward Pesicka, during a recent call to discuss the company’s earnings.
“The...
Diabetes Resupply: Seize the CGM opportunity
May 6, 2025Matt Edwards
Q. Why should HME providers consider launching a continuous glucose monitor resupply program now?
A. Diabetes impacts more than 37 million Americans, many of whom rely on daily glucose monitoring to manage their condition and prevent serious complications. In recent years, the standard of care has evolved with the widespread adoption of CGMs—small, wearable devices that provide real-time glucose readings through a sensor placed under the skin. As these devices become more mainstream,...